InvoCare Ltd.

Invocare is a provider of services in the funeral industry in Australia, New Zealand and Singapore with smaller operations in Hong Kong and the U.S. Through its associate, Co. provides online memorial services to allow families and communities to celebrate the life of a loved one.
  • TickerIVC
  • ISINAU000000IVC8
  • ExchangeAustralian Securities Exchange
  • SectorGeneral Retailers
  • CountryAustralia

INVOCARE loses on its star level and is downgraded to Slightly Positive

The independent financial analyst theScreener just slightly lowered the general evaluation of INVOCARE (AU), active in the Personal Products & Services industry. The title has lost a star(s) at the fundamental level and now shows 1 out of 4 stars. Its exposure to market risk remains nonetheless the same and can be still described as defensive. theScreener slightly downgrades the general evaluation to Slightly Positive for the title on account of the lost star(s). As of the analysis date September 22, 2020, the closing price was AUD 9.46 and its potential was estimated at AUD 11.65.

InvoCare Limited: 1 director sold

A director at InvoCare Limited sold 40,000 shares at 14.010AUD and the significance rating of the trade was 56/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of boa...

Feasibility Study Results in December to be a Catalyst for this Junior

Feasibility Study Results in December to be a Catalyst for this Junior

Daniel Ragonese

Morningstar | Improving Market Conditions Help Invocare Performance in 1Q of Fiscal 2019

Wide-moat-rated Invocare has commenced its earnings recovery with a strong start to fiscal 2019. We have not changed our AUD 16.00 per share fair value estimate, to which the firm currently trades at a slight discount. Gross revenue is up 8% on the previous corresponding period, or pcp, which is tracking marginally ahead of our full-year 6% forecast. The stronger-than-expected growth mainly reflects an improvement in market conditions, with the number of deaths reverting towards the long-term trend after having declined by 3% in fiscal 2018. Additionally, we attribute the growth to strong resu...

Daniel Ragonese

Morningstar | Improving Market Conditions Help Invocare Performance in 1Q of Fiscal 2019. See Updated Analyst Note from 15 May 2019

Wide-moat-rated Invocare has commenced its earnings recovery with a strong start to fiscal 2019. We have not changed our AUD 16.00 per share fair value estimate, to which the firm currently trades at a slight discount. Gross revenue is up 8% on the previous corresponding period, or pcp, which is tracking marginally ahead of our full-year 6% forecast. The stronger-than-expected growth mainly reflects an improvement in market conditions, with the number of deaths reverting towards the long-term trend after having declined by 3% in fiscal 2018. Additionally, we attribute the growth to strong resu...

InvoCare Limited: 1 director sold

A director at InvoCare Limited sold 40,000 shares at 14.010AUD and the significance rating of the trade was 56/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of boa...